177 E COLORADO BLVD, PASADENA, CA
Market cap: $8.6B (2/10/2026)
Price: $61.55
Reports Fiscal 2026 First Quarter Results
Annual Report to Security Holders
Arrowhead Pharmaceuticals Issues $700 Million Convertible Senior Notes
Prices Upsized Offerings of Convertible Senior Notes, Common Stock and Pre-Funded Warrants
Investor Presentation
Reports 2025 Fiscal Year-End Results
Q1
FY 2024
Amended Annual Report
Q3
Q2
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Notice of Proposed Sale of Securities
Prospectus filed pursuant to Rule 305(b)(2)
Free Writing Prospectus